| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Amyotrophic lateral sclerosis | 5 | 0 | |
| Support immune health | 2 | 3 | |
| Anoxic brain injury | 1 | 0 | |
| Chronic lymphocytic leukemia | 1 | 2 | |
| Human immunodeficiency virus (HIV) | 1 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 1 | |
| Mild | 0 | |
| None | 5 |